Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.
about
BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overloadPeritoneal Dialysis in Western CountriesOvercoming the Underutilisation of Peritoneal DialysisIncreasing the use of biocompatible, glucose-free peritoneal dialysis solutionsAliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in ratsShorter daily dwelling time in peritoneal dialysis attenuates the epithelial-to-mesenchymal transition of mesothelial cells.Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal functionHuman Peritoneal Mesothelial Cell Death Induced by High-Glucose Hypertonic Solution Involves Ca2+ and Na+ Ions and Oxidative Stress with the Participation of PKC/NOX2 and PI3K/Akt PathwaysHigh glucose concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients.Previous renal replacement therapy time at start of peritoneal dialysis independently impact on peritoneal membrane ultrafiltration failureGenetic Polymorphisms and Peritoneal Membrane Function.The solution to better preservation of the peritoneal membrane still lies hidden in the solution.Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)†Comparison of Long-Term Outcomes between Peritoneal Dialysis Patients with Diabetes as a Primary Renal Disease or as a Comorbid Condition.Safety issues of long-term glucose load in patients on peritoneal dialysis--a 7-year cohort study.Peritoneal Dialysate Glucose Load and Systemic Glucose Metabolism in Non-Diabetics: Results from the GLOBAL Fluid Cohort StudyInterstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis.Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells.Different Risk of Common Gastrointestinal Disease Between Groups Undergoing Hemodialysis or Peritoneal Dialysis or With Non-End Stage Renal Disease: A Nationwide Population-Based Cohort Study.A Patient on Peritoneal Dialysis with Refractory Volume OverloadThe balANZ study--strengthening the evidence for neutral-pH solutions low in glucose degradation productsThe influence of initial peritoneal transport characteristics, inflammation, and high glucose exposure on prognosis for peritoneal membrane function.Time course of peritoneal function in automated and continuous peritoneal dialysis.Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan.Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis.Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis.HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium.IL-10 differentially controls the infiltration of inflammatory macrophages and antigen-presenting cells during inflammation.Serum potassium levels and its variability in incident peritoneal dialysis patients: associations with mortalityInterleukin-6 signaling drives fibrosis in unresolved inflammation.Biocompatible peritoneal dialysis fluids: clinical outcomes.Interference of peritoneal dialysis fluids with cell cycle mechanisms.Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD?Peritoneal dialysis: from bench to bedside.The Association Between Glucose Exposure and the Risk of Peritonitis in Peritoneal Dialysis Patients.No increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four months.The relationship between effluent potassium due to cellular release, free water transport and CA125 in peritoneal dialysis patients.Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.Level of 8-OHdG in drained dialysate appears to be a marker of peritoneal damage in peritoneal dialysis.
P2860
Q24795280-2937EABC-0DD7-4079-B2FF-1487AC60B3EBQ24796661-CBE9AD9B-47EA-44B6-B24E-2CFC0079923FQ26740468-E4C72E70-52C1-4396-8867-5563115C6ED6Q26774019-C1E363AF-9C83-4CAE-A800-9B98F1DF3152Q28082263-6F9B413A-C662-4239-9FD1-D90712CC503EQ28730295-1B96277E-20A9-41CB-9C9F-46D18AB2C051Q33588284-48797EA7-52A4-4A58-A144-012F3134AE35Q33693392-5F532521-F0E5-42D2-A652-851745919B36Q33790023-269DE313-9619-43F0-90A6-9C490913EF33Q35106085-8AC1B7D7-D475-47F3-B4DA-285E94C5750FQ35240129-6E65B74F-04B6-4375-B9DA-99D7C6D9E8FAQ35419909-E585585E-EB12-4A17-8C77-7C7289567681Q35524650-9AE819C4-896A-4D68-AFF7-EB2AF7EE9D6AQ35587014-7B6E89F4-63EA-4E87-895C-83FD457BFA73Q35593665-150245EA-66FB-4920-B89B-70DABCC03059Q35690340-D4A1860B-936B-4894-8879-25B5BCF9AA07Q36036289-340828F1-C715-4206-BAD7-B3AD48AA4376Q36104878-BAF1FEFF-A860-436B-9CBC-9A2070A75A02Q36162579-8BEC32D2-1ADD-4604-960E-D9A8B926FC94Q36194863-4AF3C994-9CCB-4D20-905D-D5AAA0E807A1Q36432873-694A0824-81EB-4404-8876-2DDE3D891290Q36474231-041026AF-2E90-45E9-8037-89EECF07521BQ36474303-F9FEFB47-BF9F-411E-85E3-055E8D243549Q36474329-9F7C0802-CD73-40A4-B058-4D9D5B98EDF5Q36475639-26581920-AA86-431B-A90C-9FC6099BC647Q36831478-06D5FFDB-97C7-45C8-857D-6EA356623A3DQ37046408-D19F6429-26DA-438F-A5D1-D29EF8AE419DQ37123291-77B107CD-E799-4921-891B-A765FD201971Q37261611-2320FA33-F25C-44BD-AA75-4BA0DE92F2BCQ37520876-9D0655B7-1BEE-4AB3-956B-39512C13F411Q37572817-2F49F25A-EC4C-4DAE-ADD3-57A3AFD7A1BAQ38068420-127ED467-CED5-436A-A387-35D7F8063881Q38474258-515A4547-0ABE-4A8C-B40B-5F46AC4CD2ADQ38487275-1ED06D49-138A-459A-AECA-4B05B725895EQ38539729-ED2DB390-8F86-4569-930C-581E131AEAAFQ38798159-CC081B34-347D-4D60-892A-C7C0511E90D6Q40072172-BDFE7C57-F413-4B1D-AEEE-2180AE4669D8Q40318933-179D9222-D027-4639-9345-ECAF6BCBA546Q40621855-4F96A238-0BDE-4D79-A639-864A6A096951Q41066392-5F8C2F7D-327D-4ED2-82B9-99D3FC140CDA
P2860
Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Peritoneal glucose exposure an ...... h time on peritoneal dialysis.
@en
Peritoneal glucose exposure an ...... h time on peritoneal dialysis.
@nl
type
label
Peritoneal glucose exposure an ...... h time on peritoneal dialysis.
@en
Peritoneal glucose exposure an ...... h time on peritoneal dialysis.
@nl
prefLabel
Peritoneal glucose exposure an ...... h time on peritoneal dialysis.
@en
Peritoneal glucose exposure an ...... h time on peritoneal dialysis.
@nl
P2093
P1476
Peritoneal glucose exposure an ...... h time on peritoneal dialysis.
@en
P2093
P304
P577
2001-05-01T00:00:00Z